Skip to contentA
Accendra Health Inc
A
ACHAccendra Health Inc Q4 2017 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$2.39B$2.39Bderived+0.9% vs Q4 2016 Net Income$23.00M$23.00Mderived−15.2% vs Q4 2016 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Accendra Health Inc · CIK 75252 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$315,211,000+6.9% Operating Incomederived-$8,774,000N/M Operating Cash Flowderived$51,129,000+18.4% Free Cash Flowderived$41,479,000+13.4% Margins · derivedGross margin13.2%+0.7 pt vs Q4 2016
Operating margin-0.4%−2.4 pt vs Q4 2016
Net margin1.0%−0.2 pt vs Q4 2016
ended Dec 31, 2017 · filed Feb 23, 2018 · 54 d after period end